Skip to main content
Marin Kollef, MD, Pulmonology, Saint Louis, MO, Barnes-Jewish Hospital

MarinHKollefMD

Pulmonology Saint Louis, MO

Critical Care Medicine, Pleural Disease

Professor, Internal Medicine, Washington University School of Medicine

Are you Dr. Kollef?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 68 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Marin Kollef, MD is a pulmonologist in Saint Louis, Missouri. He is currently licensed to practice medicine in Missouri. He is affiliated with Barnes-Jewish Hospital and is a Professor at Washington University School of Medicine.

Education & Training

  • Madigan Army Medical Center
    Madigan Army Medical CenterFellowship, Pulmonary Disease, 1986 - 1988
  • Madigan Army Medical Center
    Madigan Army Medical CenterResidency, Internal Medicine, 1983 - 1986
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1983

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 1992 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2000

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Multidrug-Resistant Gram-Negative Infections Treatable with Newer Antibiotics, but Guidance Is Needed
    Multidrug-Resistant Gram-Negative Infections Treatable with Newer Antibiotics, but Guidance Is NeededDecember 9th, 2022
  • Ceftolozane/Tazobactam Efficacious for Ventilated Nosocomial Pneumonia
    Ceftolozane/Tazobactam Efficacious for Ventilated Nosocomial PneumoniaApril 16th, 2019
  • Results of Phase 3 Trial Evaluating Merck’s ZERBAXA
    Results of Phase 3 Trial Evaluating Merck’s ZERBAXAApril 13th, 2019
  • Join now to see all

Hospital Affiliations